B cell dysregulation during acute COVID-19 is transient.
Saved in:
| Title: | B cell dysregulation during acute COVID-19 is transient. |
|---|---|
| Authors: | Jokiranta ST; Department of Bacteriology and Immunology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland. Electronic address: suvi.jokiranta@helsinki.fi., Nguyen Ngoc A; Department of Bacteriology and Immunology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Huang X; Department of Bacteriology and Immunology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Nowlan K; Department of Bacteriology and Immunology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Hannolainen L; Department of Virology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Pyöriä L; Department of Virology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Pekkarinen PT; Department of Bacteriology and Immunology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Division of Intensive Care Medicine, Department of Anaesthesiology and Intensive Care, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Dürnsteiner P; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Lääveri T; Infectious Diseases, Inflammation Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Aalto University, Department of Computer Science, School of Science, Espoo, Finland., Heikkilä N; Department of Bacteriology and Immunology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Heinonen S; New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Laakso SM; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Department of Neurology, HUS Brain Center, Helsinki University Hospital, Helsinki, Finland., Kantele A; Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Meilahti Infectious Diseases and Vaccine Research Center, MeiVac, Department of Infectious Diseases, University of Helsinki, Helsinki, Finland., Vapalahti O; Department of Virology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Viral Zoonoses Research Unit, Department of Virology, Medicum, University of Helsinki, Helsinki, Finland; Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland; HUS Diagnostic Center, Clinical Microbiology, Helsinki University Hospital, Helsinki, Finland., Strandin T; Viral Zoonoses Research Unit, Department of Virology, Medicum, University of Helsinki, Helsinki, Finland., Hepojoki J; Department of Virology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Viral Zoonoses Research Unit, Department of Virology, Medicum, University of Helsinki, Helsinki, Finland; University of Zürich, Vetsuisse Faculty, Institute of Veterinary Pathology, Zürich, Switzerland., Perdomo MF; Department of Virology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Kekäläinen E; Department of Bacteriology and Immunology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland; HUS Diagnostic Center, Clinical Microbiology, Helsinki University Hospital, Helsinki, Finland. |
| Source: | Immunology letters [Immunol Lett] 2026 Feb; Vol. 277, pp. 107086. Date of Electronic Publication: 2025 Sep 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7910006 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0542 (Electronic) Linking ISSN: 01652478 NLM ISO Abbreviation: Immunol Lett Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
